DBT

Woebot Health Wins MedTech Breakthrough’s Mental Health Innovation Award

Retrieved on: 
목요일, 5월 9, 2024
Mental Health, Health, Technology, Telemedicine, Virtual Medicine, Health Technology, Software, Artificial Intelligence, Medtech, Interpersonal psychotherapy, Element, Cognitive behavioral therapy, Heart, EHR, Collection, Artificial intelligence, Electronic health record, DBT, Telehealth, Medical device, Mental health, Multimedia, IPT, CBT, Nursing

Woebot Health today announced that it has won the “Mental Health Innovation Award” in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.

Key Points: 
  • Woebot Health today announced that it has won the “Mental Health Innovation Award” in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.
  • “We’re thrilled and honored to once again receive an award from MedTech Breakthrough,” said Woebot Health CEO Michael Evers.
  • “’Woebot Health is addressing this challenge head on, standing as a mental health ally that is engaging people in their breakthrough mental health solutions at scale.
  • We extend our sincere congratulations to the Woebot Health team for taking home our Mental Health Innovation Award in 2024.”

Newport Healthcare Announces Specialized Substance Use Disorder Treatment for Teens and Young Adults

Retrieved on: 
수요일, 5월 8, 2024
Dialectical behavior therapy, Fentanyl, Drug, Drug overdose, Chronic pain, EMDR, Cognitive behavioral therapy, MAT, Adventure therapy, Health, PTSD, Region, Trauma, Family therapy, Cocaine, IOP, Depression, Yoga, DBT, Nonoshita, Intensive outpatient program, Methamphetamine, Betty Ford Center, Music, CBT, Prohibition, PHP, Anxiety, Nursing

To address this persistent crisis, Newport Healthcare has announced specialized substance use disorder treatment for teens and young adults ages 12-35.

Key Points: 
  • To address this persistent crisis, Newport Healthcare has announced specialized substance use disorder treatment for teens and young adults ages 12-35.
  • Currently recognized as the leading treatment provider for teens and young adults with primary mental health disorders, Newport has expanded its programming to meet the needs of clients and families struggling with addiction.
  • "Now, with our full continuum of SUD care, we can support teens and young adults throughout their recovery process as they create the foundation for a thriving, substance-free life."
  • Newport offers substance use disorder treatment (often referred to as "rehab") for teens and young adults via residential treatment, Partial Hospitalization Programs (PHP), Intensive Outpatient Programs (IOP), Medication-Assisted Treatment (MAT), and detoxification services (available in select areas).

Semiconductor Tech Firm IceMOS Technology One of Only Ten Exceptional Exporters Honoured in UK Government’s Made in the UK, Sold to the World Awards

Retrieved on: 
화요일, 4월 23, 2024
MEMS, MBE, Isles, Export, Research, IOE, Business, Growth, DBT, International trade, CO2

Recognized in the Advanced Manufacturing & Construction category, IceMOS Technology is a privately held semiconductor technology corporation and manufacturer of a new class of MEMS-based (microelectromechanical systems-based) power and sensing advanced semiconductor technologies.

Key Points: 
  • Recognized in the Advanced Manufacturing & Construction category, IceMOS Technology is a privately held semiconductor technology corporation and manufacturer of a new class of MEMS-based (microelectromechanical systems-based) power and sensing advanced semiconductor technologies.
  • The proven technology serves wide-ranging applications anywhere that power efficiency and sensing matters.
  • Through strategic global exports, IceMOS has not only expanded its customer base but fortified the resilience of the UK semiconductor sector.
  • With a strong focus on market diversification, IceMOS has achieved remarkable growth and now serves over 150 customers.”

Recovery Centers of America Achieves Strong Outcomes from Innovative Evidence-Based Care Model for Addiction Treatment

Retrieved on: 
수요일, 4월 10, 2024
Addiction, RCA, MAT, Medical diagnosis, Insurance, Substance use disorder, Research, DBT, Medication, Patient, Mental health, Patient satisfaction, Dialectical behavior therapy, NIAAA, Hospital

Fresh Start (Pathway 2): For returning/relapse patients, focuses on addressing gaps in previous recovery experience and identifying top triggers.

Key Points: 
  • Fresh Start (Pathway 2): For returning/relapse patients, focuses on addressing gaps in previous recovery experience and identifying top triggers.
  • New data shows that the outcomes of RCA’s model is surpassing national standards and other recovery centers, including:
    RCA’s readmission rates are below national expectations.
  • "RCA's evidence-based care model represents a distinctive, innovative, and patient-centered approach to treating addiction and fostering lasting recovery," said Brett Cohen, CEO of RCA.
  • For more information about RCA’s care model and the new findings about its success, please visit Recovery Centers of America .

Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)

Retrieved on: 
화요일, 4월 23, 2024
Mental Health, Women, FDA, Baby, Maternity, Clinical Trials, Biotechnology, Health, Consumer, Pharmaceutical, American College, Regulation, PPD, Woman, Behavioral activation, Food, Cognitive behavioral therapy, BAT, Depression, DBT, Smartphone, Summer, ACOG, Therapy, Edinburgh Postnatal Depression Scale, Patient, MPH, Postpartum depression, Face, ITT, IPT, RCT, Dialectical behavior therapy, CBT, EPDS

Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM.

Key Points: 
  • Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM.
  • MamaLift Plus treats mild to moderate postpartum depression by improving a patient’s symptoms of depression.
  • MamaLift Plus delivers digital Cognitive Behavioral Therapy (CBT), Behavioral Activation Therapy (BAT), Interpersonal Therapy (IPT), and Dialectical Behavior Therapy (DBT) for postpartum depression.
  • The clearance of MamaLift Plus is based on results from the Supporting Maternal Mental Health and Emotional Regulation (SuMMER).

QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis

Retrieved on: 
화요일, 4월 16, 2024
Research, Medical Devices, Women, Clinical Trials, Biotechnology, Radiology, Consumer, Health, Science, Oncology, FDA, University, ROC, Cancer, Woman, Breast cancer, Breast disease, Tomosynthesis, MD, 3D, DBT, QTI, Patient, MRMC, AUC, Recall, Medical imaging

The study found that QTI’s Breast Acoustic CTTM is similarly effective as digital breast tomosynthesis (DBT), also known as 3D mammography, in that the area under receiver operating characteristic curve (AUC) was statistically non-inferior for QTI scan compared with DBT for the AUC difference margin of -0.05.

Key Points: 
  • The study found that QTI’s Breast Acoustic CTTM is similarly effective as digital breast tomosynthesis (DBT), also known as 3D mammography, in that the area under receiver operating characteristic curve (AUC) was statistically non-inferior for QTI scan compared with DBT for the AUC difference margin of -0.05.
  • This means that QTI technology is non-inferior to DBT in the detection of breast lesions as a whole, with high specificity in determining benign cysts and thus decreasing benign recall rates.
  • Unfortunately, routine screening mammograms are not recommended for women under 40 because risks outweigh potential benefits at this young age.
  • Fortunately, the now published results suggest that QTI’s technology can be a much-needed potential alternative to mammography for women too young to undergo mammography screening.

GE HealthCare to feature Mobile Mammography Screening Truck along with Latest AI Platform as part of SBI2024 Breast Cancer Imaging Showcase

Retrieved on: 
금요일, 4월 12, 2024
Other Consumer, Women, Other Health, Photography, Radiology, Oncology, Software, Artificial Intelligence, Medical Devices, Hospitals, Electronic Design Automation, Consumer, Technology, General Health, Biotechnology, Health, Apps, Applications, Health Technology, FDA, Cancer, Boston Medical Center, CME, GE HealthCare, Woman, Publication, Malignancy, SBI, Breast cancer, Workplace, Research, Pathology, Artificial intelligence, DBT, CEM, Patient, Biopsy, Diagnosis, Self-assessment, Breast, Medical imaging

GE HealthCare (Nasdaq: GEHC), a leader in breast health technology and diagnostics, will feature its latest breast cancer detection technology during the 2024 Society of Breast Imaging Symposium in Montreal, Canada, April 11-14, 2024.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC), a leader in breast health technology and diagnostics, will feature its latest breast cancer detection technology during the 2024 Society of Breast Imaging Symposium in Montreal, Canada, April 11-14, 2024.
  • This year’s showcase will feature the Mobile Mammography Screening Truck, the recently released MyBreastAI Suite* and Pristina Bright** offering to demonstrate the company’s personalized approach to transforming breast cancer imaging.
  • The truck is equipped with the Senographe Pristina and Invenia ABUS to ensure accurate and efficient screenings.
  • *MyBreastAI suite is a commercial offering that includes GE HealthCare’s Edison Health Services platform, ProFound AI® for DBT, SecondLook for 2D Mammography and PowerLook® Density Assessment.

Iris Wellness Group Launches Outpatient Drug and Alcohol Detox Program in Chattanooga, TN

Retrieved on: 
금요일, 4월 26, 2024
Family therapy, Cognitive behavioral therapy, Spectrum, Art therapy, DBT, Patient, Music therapy, CBT, Dialectical behavior therapy, Person, Health care

CHATTANOOGA, Tenn., April 26, 2024 /PRNewswire-PRWeb/ -- Iris Wellness Group is excited to announce the launch of its innovative Outpatient Drug and Alcohol Detox Program, dedicated to providing personalized and accessible care to teens, adolescents, and adults struggling with addiction. Officially launched on April 15th, 2024, this pioneering program offers a unique approach to detoxification, which allows patients to maintain their daily lives while receiving critical support.

Key Points: 
  • Iris Wellness Group has introduced an Outpatient Drug and Alcohol Detox Program in Chattanooga, TN, offering personalized care for individuals grappling with addiction.
  • Launched on April 15th, 2024, this unique detox program allows patients to maintain their daily routines while receiving crucial support.
  • CHATTANOOGA, Tenn., April 26, 2024 /PRNewswire-PRWeb/ -- Iris Wellness Group is excited to announce the launch of its innovative Outpatient Drug and Alcohol Detox Program , dedicated to providing personalized and accessible care to teens, adolescents, and adults struggling with addiction.
  • Understanding that recovery from addiction is deeply personal, Iris Wellness Group integrates various therapeutic modalities to cater to individual needs.

Suffolk DBT Expands to Meet the Growing Need for Self-Harm, Suicidal Thoughts, and Depression Therapy.

Retrieved on: 
금요일, 4월 26, 2024
LCSW, COVID, Learning, Self-harm, Depression, DBT, Pressure, Patient, Face, Borderline personality disorder, Anxiety, Yahoo!

LONG ISLAND, N.Y., April 25, 2024 /PRNewswire-PRWeb/ -- Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy treatment in Long Island, Manhattan, Suffolk, and Nassau Counties. This expansion is the first of many changes coming in 2024 as Suffolk DBT continues to serve their patients and communities.

Key Points: 
  • Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy treatment in Long Island, Manhattan, Suffolk, and Nassau Counties.
  • This expansion is the first of many changes coming in 2024 as Suffolk DBT continues to serve their patients and communities.
  • This expansion is the first of many changes coming in 2024 as Suffolk DBT continues to serve their patients and communities.
  • "The number of people dealing with depression, anxiety, self-harm, anger management, borderline personality disorder, suicidal thinking/behavior, and other serious mental health issues has risen dramatically.

CooperRiis - Expands Mental Health Care Access in North Carolina - Now In-Network with Blue Cross Blue Shield

Retrieved on: 
월요일, 4월 15, 2024
ACT, Case management, Dialectical behavior therapy, Psychiatry, Bipolar disorder, PTSD, Schizoaffective disorder, Insurance, Partnership, Depression, Psychotherapy, Schizophrenia, DBT, Mental health, Personality, Helsinki University Central Hospital, Commitment, Hospital, Therapy, PHP, Anxiety

ASHEVILLE, N.C., April 15, 2024 /PRNewswire-PRWeb/ -- CooperRiis, a non-profit mental health treatment program, announces it is now in-network with Blue Cross Blue Shield of North Carolina with two of its leading programs:

Key Points: 
  • CooperRiis, a non-profit mental health treatment program, announces it is now in-network with Blue Cross Blue Shield of North Carolina with two of its leading programs.
  • By adding additional insurance plans, CooperRiis offers more North Carolinians access to ground-breaking mental health care.
  • The PHP is a day program that offers stabilization following hospitalization with more intensive care than a doctor's or therapist's office.
  • We believe that everyone deserves access to quality mental health care and this partnership with Blue Cross Blue Shield of North Carolina is a significant step towards realizing that vision."